About Twilight Litaka Pharma Limited
Data last updated:
Twilight Litaka Pharma Limited is a public limited company based in Pune, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 1974.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN L24231MH1974PTC017139. It is recorded as listed by MCA, but its shares were delisted from NSE on 02 Jul 2018 · winding up and from BSE on 14 Feb 2020 · winding up, and no longer trade on a stock exchange.
The company has an authorised share capital of ₹21.5 Cr and a paid-up capital of ₹12.39 Cr. It is led by directors including Gopal Kupposwami Ramourti (Managing Director) and Nainish Rajendra Bora (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 December 2013, and its latest financial statements are for the year ended 30 June 2013. The registered office is at B – 22 H Block MIDC Pimpri, Pune, Maharashtra, India – 411018.
As per the financials filed for FY 2014, the company reported a revenue of ₹31.51 Cr, a decline of 91% compared to the previous year.
The company is associated with 1 brand: Twilight Litaka Pharma. As per MCA filings, the company has open charges of ₹454.9 Cr and satisfied charges of ₹125.18 Cr on record. Court records list 239 cases involving the company, including 52 filed by the company and 187 filed against it; 29 cases are pending. The company has 45 deals on record (44 market trades, 1 secondary share transfer); the latest was in March 2013. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Celogen Pharma Private Limited with revenue of ₹31.72 Cr.
The last known website on record is twilightlitaka.com.
Company details
Contact details
Twilight Litaka Pharma Limited's registered office is in Pune, Maharashtra.
- Registered AddressB – 22 H Block MIDC Pimpri, Pune, Maharashtra, India – 411018
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Twilight Litaka Pharma operates one associated brand: Twilight Litaka Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops innovative technologies for drugs and formulations. | twilightlitaka.com |
Financials of Twilight Litaka Pharma Limited
FY 2013 filings availableTwilight Litaka Pharma Limited reported revenue of ₹31.51 Cr (down 91% YoY) for FY 2014.
Compounded Annual Growth Rate (CAGR)
Revenue fell 91% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2013-14 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2013-14 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Twilight Litaka Pharma Limited, buy the company report.
Board of directors of Twilight Litaka Pharma Limited
Twilight Litaka Pharma has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Raghavan Mathurakavi Ayyangar | Director | 31 Dec 2005 | 20 Years 9 Months | As last reported |
| Avinash Shantaram Chandvankar Also directs: Briocia Pharma (India ) Limited | Director | 20 Apr 2002 | 24 Years 6 Months | As last reported |
| Nainish Rajendra Bora | Whole-Time Director | 25 Mar 2005 | 21 Years 6 Months | As last reported |
| Gopal Kupposwami Ramourti Also directs: Briocia Pharma (India ) Limited, Twilight Mercantiles Limited | Managing Director | 30 Jun 2005 | 21 Years 3 Months | As last reported |
Peer comparison
Twilight Litaka Pharma Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Celogen Pharma Private Limited | ₹31.72 Cr (FY 2024) | 1.0% | Navi Mumbai, Maharashtra, India | |||
| Proqol Health Care Private Limited | ₹31.67 Cr (FY 2025) | 48.0% | Chennai, Tamil Nadu, India | |||
| KNVM Medicare Private Limited | ₹31.57 Cr (FY 2025) | 31.0% | Ghaziabad, Uttar Pradesh, India | |||
| Nem Laboratories Pvt Ltd | ₹31.56 Cr (FY 2025) | 3.0% | Thane, Maharashtra, India | |||
| Novalab Health Care Private Limited | ₹31.54 Cr (FY 2024) | 25.0% | Muzaffarpur, Bihar, India | |||
| Twilight Litaka Pharma Limitedthis company | ₹31.51 Cr (FY 2014) | -91.0% | Pune, Maharashtra, India | |||
| Sarvotham Care Limited | ₹31.32 Cr (FY 2024) | 30.0% | Secunderabad, Telangana, India | |||
| Heet Healthcare Private Limited | ₹31.31 Cr (FY 2024) | -41.0% | Ahmedabad, Gujarat, India | |||
| Pharmaceutical Institute of India Private Limited | ₹31.28 Cr (FY 2025) | 74.0% | Cuttack, Odisha, India | |||
| Bangalore Pharmaceutical and Research Laboratory Private Limited | ₹31.23 Cr (FY 2023) | 20.0% | Bangalore, Karnataka, India | |||
| Fertin India Private Limited | ₹31.2 Cr (FY 2025) | 23.0% | Salcete, Goa, India |
To see the full peer comparison of Twilight Litaka Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jun 2012 | 10367858 | Srei Infrastructure Finance Limited | ₹5 Cr | Open | |
| 03 Jun 2011 | 10293431 | Idbi Bank Limited | ₹30 Cr | Open | |
| 23 Feb 2011 | 10276705 | State Bank of Hyderabad | ₹40 Cr | Open | |
| 30 Jul 2009 | 10167995 | Central Bank of India - Security Trustee | ₹202 Cr | Open | |
| 18 Mar 2009 | 10160409 | Central Bank of India | ₹2 Cr | Open |
To see the full charge records of Twilight Litaka Pharma Limited, buy the company report.
Total charge records: 44 View all charges
Deals & funding
Twilight Litaka Pharma Limited has 45 deals on record (44 market trades, 1 secondary share transfer); the latest was in March 2013.
Deals on record (5 of 45)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2013 | Market trade | ₹10.2 Lakh | Seller: Fervent Synergies Limited |
| May 2011 | Market trade | ₹75.6 Lakh | Seller: Ifci Factors Limited |
| Mar 2011 | Market trade | ₹89.9 Lakh | Seller: Ifci Factors Limited |
| Mar 2011 | Market trade | ₹1.26 Cr | Seller: Ifci Factors Limited |
| Mar 2011 | Market trade | ₹56.6 Lakh | Seller: Ifci Factors Limited |
To see the full deal history of Twilight Litaka Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Twilight Litaka Pharma Limited has 239 court cases on record: 52 filed by Twilight Litaka Pharma, 187 filed against it. 29 cases are pending and 210 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 182 | 153 | 19 |
| High courts | 57 | 34 | 10 |
Cases on record (5 of 239)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Icici Bank Ltd Th.Mr.Sameer Mehta | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed against the company by Sbi Global Factors Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (OLR) | Filed by the company against Edelweiss Asset Reconstruction Company Ltd. (Secured Creditro) and 7 others | Disposed |
| Bombay High Court | Appeal | Filed against the company by Invent Assets Securitisation and Reconstruction Pvt Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed against the company by Idbi Bank Ltd | Disposed |
To see the full case history of Twilight Litaka Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Twilight Litaka Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Twilight Litaka Pharma Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Twilight Litaka Pharma Limited has 26 board changes on record since 1992: 15 appointments and 11 cessations. The latest: Rajendra Chandmal Bora ceased to be Director on 10 Oct 2023.
91 earlier events are in the company report.
Frequently asked questions
Twilight Litaka Pharma is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Twilight Litaka Pharma is a company under liquidation, formerly operating as a company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 1974 and is registered under CIN L24231MH1974PTC017139. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Twilight Litaka Pharma has 4 current directors:
- Gopal Kupposwami Ramourti - Managing Director
- Nainish Rajendra Bora - Whole-Time Director
- Srinivasa Raghavan Mathurakavi Ayyangar - Director
- Avinash Shantaram Chandvankar - Director
The latest financial statements of Twilight Litaka Pharma on record with the MCA are for the year ended 30 June 2013. Its last annual general meeting was held on 30 December 2013. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Twilight Litaka Pharma is L24231MH1974PTC017139. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Twilight Litaka Pharma is recorded as a listed company by MCA, but its shares were delisted from NSE on 02 Jul 2018 · winding up and from BSE on 14 Feb 2020 · winding up, and no longer trade on a stock exchange.
Twilight Litaka Pharma has open charges of ₹454.9 Cr and satisfied charges of ₹125.18 Cr as per latest MCA filings.
Twilight Litaka Pharma has 239 court cases on record: 52 filed by the company and 187 filed against it. 29 are pending. Most are in the district courts.
Twilight Litaka Pharma was incorporated on 18 January 1974. It is registered with the Registrar of Companies, Pune.
Twilight Litaka Pharma has 45 deals on record (44 market trades, 1 secondary share transfer); the latest was in March 2013.
The peers of Twilight Litaka Pharma by revenue are Celogen Pharma Private Limited, Proqol Health Care Private Limited, KNVM Medicare Private Limited, Nem Laboratories Pvt Ltd, Novalab Health Care Private Limited and 5 more, all in the Pharma industry (Formulations).